MedTrace Logo

Evaluation of a New Technology for the Treatment of Bladder Leakage in Women

NCT04059653 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 86

Last updated 2020-07-23

No results posted yet for this study

Summary

Evaluation of a new technology for the treatment of bladder leakage in women. The objective is to compare quality of life and other incontinence associated outcomes between women receiving routine General Practitioner (GP) prescribed care for urinary incontinence compared with those prescribed the electrical stimulation device.

Conditions

Interventions

DEVICE

Electrical stimulation

Electrical stimulation device

OTHER

Treatment as usual

GP treatment as usual

Sponsors & Collaborators

  • University of Manchester

    lead OTHER

Principal Investigators

  • Jackie Oldham, PhD · Univeristy of Manchester

  • Sheila McCorkindale, MBChB FRCGP · University of Manchester

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-01-06
Primary Completion
2020-06-30
Completion
2020-06-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04059653 on ClinicalTrials.gov